Skip to main content
Have a personal or library account? Click to login
Pre-treatment antinuclear antibody positivity, therapeutic efficacy and persistence of biologics in rheumatoid arthritis Cover

Pre-treatment antinuclear antibody positivity, therapeutic efficacy and persistence of biologics in rheumatoid arthritis

Revista Romana de Medicina de Laborator
Volume 24 (2016): Issue 2 (June 2016)
By: ,  ,  ,  ,  ,  ,   and    
Open Access
|Jun 2016
References

References

  1. 1. Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M, et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology. 1995;21(3):613-9. DOI: 10.1016/0270-9139(95)90507-3 DOI: 10.1002/hep.1840210302.
    Open DOISearch in Google Scholar
  2. 2. Bonnet F, Pineau JJ, Taupin JL, Feyler A, Bonarek M, de WS, et al. Prevalence of cryoglobulinemia and serological markers of autoimmunity in human immunodeficiency virus infected individuals: a cross-sectional study of 97 patients. JRheumatol. 2003;30(9):2005-10.
    Search in Google Scholar
  3. 3. Imran A, Neelam F, Tariq M. Incidence of circulating antinuclear antibodies in cancer patients. Indian JMedSci. 2003;57(3):113-6.
    Search in Google Scholar
  4. 4. Qadan LR, Ahmed AA, Abdel-Jalil S, Al-Bader MA. Significance of antinuclear antibodies and rheumatoid factor in patients with advanced peripheral arterial disease. MedPrincPract. 2010;19(3):192-5. DOI: 10.1159/000273071.
    Open DOISearch in Google Scholar
  5. 5. Rich S, Kieras K, Hart K, Groves BM, Stobo JD, Brundage BH. Antinuclear antibodies in primary pulmonary hypertension. JAmCollCardiol. 1986;8(6):1307-11. DOI: 10.1016/s0735-1097(86)80301-1.
    Open DOISearch in Google Scholar
  6. 6. Yukawa N, Fujii T, Kondo-Ishikawa S, Yoshifuji H, Kawabata D, Nojima T, et al. Correlation of antinuclear antibody and anti-double-stranded DNA antibody with clinical response to infliximab in patients with rheumatoid arthritis: a retrospective clinical study. Arthritis ResTher. 2011;13(6):R213. DOI: 10.1186/ar3546.
    Open DOISearch in Google Scholar
  7. 7. Nisihara R, Kubis MM, Rodrigues PC, Skare T, Mocelin V, Utiyama S. Antinuclear antibodies and rheumatoid factor positivity in healthy elderly adults: a cross-sectional study in 336 individuals. JAmGeriatrSoc. 2013;61(11):2044-6. DOI: 10.1111/jgs.12533.
    Open DOISearch in Google Scholar
  8. 8. Nishimura S, Nishiya K, Hisakawa N, Chikazawa H, Ookubo S, Nakatani K, et al. Positivity for antinuclear antibody in patients with advanced rheumatoid arthritis. Acta MedOkayama. 1996;50(5):261-5.
    Search in Google Scholar
  9. 9. Muzellec Y, Le GP, Jouquan J, Fauquert P, Muller S, Youinou P. Antibodies to histones in rheumatoid arthritis. DiagnClinImmunol. 1988;5(6):326-31.
    Search in Google Scholar
  10. 10. Glossop JR, Dawes PT, Mattey DL. Antinuclear antibodies are associated with tumor necrosis factor receptor I gene polymorphism in patients with rheumatoid arthritis. ClinExpRheumatol. 2011;29(4):609-15.
    Search in Google Scholar
  11. 11. Jacobsen S. Young age of onset is associated with increased prevalence of circulating IgM rheumatoid factor and antinuclear antibodies at presentation in women with rheumatoid arthritis. ClinRheumatol. 2004;23(2):121-2. DOI: 10.1007/s10067-003-0844-9.
    Open DOISearch in Google Scholar
  12. 12. Caspi D, Elkayam O, Eisinger M, Vardinon N, Yaron M, Burke M. Clinical significance of low titer anti-nuclear antibodies in early rheumatoid arthritis: implications on the presentation and long-term course of the disease. RheumatolInt. 2001;20(2):43-7. DOI: 10.1007/ s002960000073.
    Open DOISearch in Google Scholar
  13. 13. Young A, Koduri G. Extra-articular manifestations and complications of rheumatoid arthritis. BestPractResClinRheumatol. 2007;21(5):907-27. DOI: 10.1016/j.berh.2007.05.007.
    Open DOISearch in Google Scholar
  14. 14. Smolen JS, Landewe R, Breedveld FC, Buch M, Burmester G, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. AnnRheumDis. 2014;73(3):492-509. DOI: 10.1136/annrheumdis-2013-204573.
    Open DOISearch in Google Scholar
  15. 15. Jilani AA, Mackworth-Young CG. The role of citrullinated protein antibodies in predicting erosive disease in rheumatoid arthritis: a systematic literature review and meta-analysis. IntJRheumatol. 2015;2015:728610. DOI: 10.1155/2015/728610.
    Open DOISearch in Google Scholar
  16. 16. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, III, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/ European League Against Rheumatism collaborative initiative. AnnRheumDis. 2010;69(9):1580-8. DOI: 10.1002/art.27584 DOI: 10.1136/ard.2010.138461.
    Open DOISearch in Google Scholar
  17. 17. Prevoo ML, van ‘t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis Arthritis Rheum. 1995;38(1):44-8. DOI: 10.1002/ art.1780380107.
    Open DOISearch in Google Scholar
  18. 18. Innala L, Berglin E, Moller B, Ljung L, Smedby T, Sodergren A, et al. Age at onset determines severity and choice of treatment in early rheumatoid arthritis: a prospective study. Arthritis research & therapy. 2014;16(2):R94. DOI: 10.1186/ar4540.
    Open DOISearch in Google Scholar
  19. 19. Amaya-Amaya J, Calixto OJ, Saade-Lemus S, Calvo- Paramo E, Mantilla RD, Rojas-Villarraga A, et al. Does non-erosive rheumatoid arthritis exist? A cross-sectional analysis and a systematic literature review. Seminars in arthritis and rheumatism. 2015;44(5):489-98. DOI: 10.1016/j.semarthrit.2014.09.006.
    Open DOISearch in Google Scholar
  20. 20. Rodriguez-Carrio J, Alperi-Lopez M, Lopez P, Alonso- Castro S, Ballina-Garcia FJ, Suarez A. Angiogenic T cells are decreased in rheumatoid arthritis patients. Annals of the rheumatic diseases. 2015;74(5):921-7. DOI: 10.1136/annrheumdis-2013-204250.
    Open DOISearch in Google Scholar
  21. 21. Mathieu S, Couderc M, Pereira B, Soubrier M. The effects of TNF-alpha inhibitor therapy on arterial stiffness and endothelial dysfunction in rheumatoid arthritis: a meta-analysis. Seminars in arthritis and rheumatism. 2013;43(3):e1-2. DOI: 10.1016/j.semarthrit.2013.05.005.
    Open DOISearch in Google Scholar
  22. 22. Hsue PY, Scherzer R, Grunfeld C, Imboden J, Wu Y, Del Puerto G, et al. Depletion of B-cells with rituximab improves endothelial function and reduces inflammation among individuals with rheumatoid arthritis. Journal of the American Heart Association. 2014;3(5):e001267. DOI: 10.1161/JAHA.114.001267.
    Open DOISearch in Google Scholar
  23. 23. Lima A, Monteiro J, Bernardes M, Sousa H, Azevedo R, Seabra V, et al. Prediction of methotrexate clinical response in Portuguese rheumatoid arthritis patients: implication of MTHFR rs1801133 and ATIC rs4673993 polymorphisms. BioMed research international. 2014;2014:368681. DOI: 10.1155/2014/368681.
    Open DOISearch in Google Scholar
  24. 24. Sawalha AH, Harley JB. Antinuclear autoantibodies in systemic lupus erythematosus. CurrOpinRheumatol. 2004;16(5):534-40. DOI: 10.1097/01. bor.0000135452.62800.8f.
    Open DOISearch in Google Scholar
  25. 25. Smeenk RJ. Antinuclear antibodies: cause of disease or caused by disease? Rheumatology(Oxford). 2000;39(6):581-4. DOI: 10.1093/rheumatology/39.6.581.
    Open DOISearch in Google Scholar
  26. 26. Picerno V, Ferro F, Adinolfi A, Valentini E, Tani C, Alunno A. One year in review: the pathogenesis of rheumatoid arthritis. Clinical and experimental rheumatology. 2015;33(4):551-8.
    Search in Google Scholar
DOI: https://doi.org/10.1515/rrlm-2016-0018 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624 (formerly 2284-5623)
Journal RSS Feed
Language: English
Page range: 212 - 222
Submitted on: Oct 15, 2015
Accepted on: Apr 3, 2016
Published on: Jun 28, 2016
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Keywords:
rheumatoid arthritis;antinuclear antibodies;biological therapy
Related subjects:
Life sciences,
Molecular biology

© 2016 Cătălin Codreanu, Corina Mogoșan, Claudiu Costinel Popescu, Simona Rednic, Horațiu Popovici, Magda Pârvu, Daniela Opriș, Ruxandra Ionescu, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 24 (2016): Issue 2 (June 2016)
Previous article
Next article